AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

AbbVie (ABBV) announced the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

The global autoinjectors market size was estimated at US$ 1,505.0 million in 2019. The global autoinjectors market is expected to reach $ 9,732.6 million by 2030 by registering a compound annual ...

HAPI ETF uses a proprietary method to select 150 U.S. large-cap companies with strong corporate cultures. Learn why I rate ...

Piramal Pharma has committed to reduce its GHG emissions for Scope 1, 2, and 3 by 2030MUMBAI, India, Sept. 16, 2024 ...

AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

“The entire Orioles organization welcomes Catie as we continue to elevate every aspect of our operation.” That’s Griggs’ top priority -- to make the O’s, as well as Camden Yards, as successful as ...

According to Benzinga Pro, AbbVie's peer group average for short interest as a percentage of float is 6.31%, which means the ...

AbbVie Inc. (NYSE:ABBV), a global biopharmaceutical company, develops and sells prescription medications for various health conditions, focusing on chronic autoimmune diseases, oncology ...

AbbVie stock (NYSE: ABBV) has more than doubled in value since early January 2021 – jumping from levels of $90 then to around $195 now – vs. an increase of about 50% for the S&P 500 over this ...

Microsoft Theater on November 24, 2019 in Los Angeles, California. Post Malone charts the No. 1 rap and country albums this week, and with different projects, as The Diamond Collection rises to No ...